Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial

Nauck, Michael A.; Jensen, Thomas Jon; Rosenkilde, Carina; Calanna, Salvatore; Buse, John B.; the LEADER Publication Committee on behalf of the LEADER Trial Investigators

doi:10.2337/dc17-1825

Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial

OBJECTIVE This study explored neoplasm risk with liraglutide versus placebo in the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) cohort. RESEARCH DESIGN AND METHODS LEADER (NCT01179048) was an international, phase 3b, randomized, double-blind, co…